Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-MTAB-7847

ABSTRACT: RNA-seq of human hepatocellular carcinoma cell line Huh7 and immortalized hepatocyte cell line THLE5B treated with experimental compound AD80, Sorafenib, and vehicle for 24 hours

PROVIDER: E-MTAB-7847 | ExpressionAtlas | 2025-01-23

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-MTAB-7847-analysis-methods.tsv	Tabular
	E-MTAB-7847-analytics.tsv	Tabular
	E-MTAB-7847-atlasExperimentSummary.Rdata	Rdata
	E-MTAB-7847-configuration.xml	Xml
	E-MTAB-7847-g3_g1-mvaPlot.png	Other

Items per page:

1 - 5 of 57

Similar Datasets

RNA-seq of human hepatocellular carcinoma cell line Huh7 and immortalized hepatocyte cell line THLE5B treated with experimental compound AD80, Sorafenib, and vehicle for 24 hours

Project description:RNA-seq of human hepatocellular carcinoma cell line Huh7 and immortalized hepatocyte cell line THLE5B treated with experimental compound AD80, Sorafenib, and vehicle for 24 hours

| PRJEB32080 | ENA

E-GEOD-47739

Project description:Gene expression of hepatocyte cell line (HepG2) treated with H2O2 to induce senescence relative to control untreated cells

2025-01-24 | E-GEOD-47739 | ExpressionAtlas

E-MTAB-6756

Project description:Total RNA-seq of human oesophageal adenocarcinoma cell line OE19 treated with siNT, siHNF4A, siGATA6 and siHNF4A+siGATA6 for 72 hours

2025-01-23 | E-MTAB-6756 | ExpressionAtlas

Transcriptomic profiling of HepaRG cells with or without fat-loading

Project description:We report whole genome gene expression in HepaRG cells, a human hepatocellular carcinoma cell line, that were either treated with palmitic and oleic acid or solvent only. These data capture transcriptional events related to the response of human hepatocyte-like cells to fat-loading.

2024-01-01 | GSE185169 | GEO

E-GEOD-51627

Project description:Treatment of renal cell carcinoma cell line A-498 with zebularine

2025-01-24 | E-GEOD-51627 | ExpressionAtlas

Active repression of cell fate plasticity by PROX1 safeguards hepatocyte identity and prevents liver tumorigenesis

Project description:Cell fate plasticity enables development, yet unlocked plasticity is a cancer hallmark. Regulating cell identity requires gene activation and repression. While master regulators induce lineage-specific genes to restrict plasticity, it remains unclear whether unwanted plasticity is actively suppressed by lineage-specific repressors. Here, we computationally predict so-called safeguard repressors for 18 cell types that block phenotypic plasticity lifelong. We validated hepatocyte-specific candidates using reprogramming, revealing that Prospero homeobox protein 1 (PROX1) enhanced hepatocyte identity by direct repression of alternate fate master regulators. In line with patient data, PROX1 overexpression in mice blocked initiation and progression of hepatocellular carcinoma and extended survival. Remarkably, Prox1 depletion caused hepatocyte fate loss in vitro, and promoted transdifferentiation of hepatocellular- to cholangio-carcinoma in vivo. Our findings provide mechanistic evidence for PROX1 as a hepatocyte-specific safeguard and support a model where individual cell type-specific repressors actively suppress plasticity throughout life to safeguard lineage choice and prevent disease.

2024-11-11 | PXD053043 | Pride

E-GEOD-50803

Project description:Expression of SUDHL-1 cell line treated by ALK inhibitors

2025-01-24 | E-GEOD-50803 | ExpressionAtlas

E-MTAB-8101

Project description:Mouse melanoma cell line B16-F10 treated with G007-LK

2020-07-15 | E-MTAB-8101 | ExpressionAtlas

Genomic profiling reveals unique molecular alterations in hepatoblastomas and adjacent hepatocellular carcinomas in B3C3F1 mice

Project description:The cell of origin of hepatoblastoma in humans and mice (HB) is unknown; it has been hypothesized to be a transformed hepatocyte, an oval cell, or a multipotent hepatic progenitor cell. In mice, the current dogma is that HBs arise within hepatocellular neoplasms as a result of further transformation from a neoplastic hepatocyte. However, there is little evidence in the literature to support a direct relationship between these two cell types. Furthermore, due to differences in etiology and development of hepatoblastoma between mice and humans, many have questioned the relevance of these tumors in hazard identification and risk assessment. In order to better understand the relationship between hepatocellular carcinoma and hepatoblastoma, as well as better determine the molecular similarities between mouse and human hepatoblastoma, global gene expression analysis and targeted Hras and Ctnnb1 mutation analysis were performed using concurrent hepatoblastoma, hepatocellular carcinoma, and associated normal adjacent liver (in the context of vehicle control liver) samples from a recent National Toxicology Program chronic bioassay. The data from this study provides a better understanding of the origins of hepatoblastoma in the B6C3F1 mice and the relevance of mouse hepatoblastoma to humans when considering chemical exposures of potential human cancer risk. Compare mouse hepatoblastoma versus adjacent hepatocellular carcinomas versus adjacent non-tumor liver and vehicle control normal liver, 6 replicates each group.

2015-09-01 | E-GEOD-67316 | biostudies-arrayexpress

E-MTAB-9315

Project description:RNA-seq of CLB-GA neuroblastoma cell line treated with Celastrol against DMSO treated controls

2025-01-23 | E-MTAB-9315 | ExpressionAtlas